24-Hour Time Course of Striatal Dopamine D2 Receptor Occupancy of Ziprasidone: A PET Study.
Phase of Trial: Phase II
Latest Information Update: 07 Jul 2012
At a glance
- Drugs Ziprasidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Biomarker; Therapeutic Use
- 07 Jul 2012 Actual end date (Jun 2011) added as reported by ClinicalTrials.gov.
- 07 Jul 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 17 Jan 2009 New trial record.